BCA
Benchmark Capital Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2014
Q2 | – | Sell |
-20,800
| Closed | -$1.4M | – | 130 |
|
|
2014
Q1 | $1.4M | Sell |
20,800
-4,200
| -17% | -$282K | 0.97% | 34 |
|
|
2013
Q4 | $1.32M | Buy |
+25,000
| New | +$1.32M | 0.91% | 38 |
|
|
2013
Q3 | – | Sell |
-52,900
| Closed | -$1.98M | – | 135 |
|
|
2013
Q2 | $1.98M | Buy |
+52,900
| New | +$1.98M | 1.53% | 20 |
|